CytRx Reports 2010 Second Quarter Financial Results – Recent highlights include reported eradication of advanced-stage leukemia following treatment with tamibarotene in two additional patients –
– On track with aggressive 2010 agenda to initiate multiple Phase 2 oncology trials by year end –